Cargando…
Validation of the Cancer BioChip System as a 3D siRNA Screening Tool for Breast Cancer Targets
Genomic studies have revealed that breast cancer consists of a complex biological process with patient-specific genetic variations, revealing the need for individualized cancer diagnostic testing and selection of patient-specific optimal therapies. One of the bottlenecks in translation of genomic br...
Autores principales: | Marhefka, Joie N., Abbud-Antaki, Rula A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458802/ https://www.ncbi.nlm.nih.gov/pubmed/23049944 http://dx.doi.org/10.1371/journal.pone.0046086 |
Ejemplares similares
-
Evolution of Biochip Technology: A Review from Lab-on-a-Chip to Organ-on-a-Chip
por: Azizipour, Neda, et al.
Publicado: (2020) -
ECO/siRNA nanoparticles and breast cancer metastasis
por: Lu, Zheng-Rong, et al.
Publicado: (2015) -
Genome-wide screens for effective siRNAs through assessing the size of siRNA effects
por: Zhang, Xiaohua Douglas
Publicado: (2008) -
sIR: siRNA Information Resource, a web-based tool for siRNA sequence design and analysis and an open access siRNA database
por: Shah, Jyoti K, et al.
Publicado: (2007) -
An siRNA screen identifies the GNAS locus as a driver in 20q amplified breast cancer
por: Garcia-Murillas, Isaac, et al.
Publicado: (2013)